Gratus Capital’s Intersect ENT, Inc XENT Stock Holding History

Gratus Capital’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-68,091	Closed	-$1.53M	–	98
2015 Q4	$1.53M	Buy	68,091 +3,440	+5%	+$68K	0.35%	49
2015 Q3	$1.51M	Buy	64,651 +19,465	+43%	+$537K	0.37%	59
2015 Q2	$1.29M	Buy	45,186 +2,446	+6%	+$64.1K	0.3%	62
2015 Q1	$1.1M	Buy	+42,740	New	+$977K	0.25%	66

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gratus Capital's XENT Position: Q1 2016 in Review

Gratus Capital sold out of Intersect ENT, Inc (XENT) in Q1 2016, closing a stake of 68,091 shares — an estimated $1.53M sold.

Gratus Capital first reported a position in XENT in Q1 2015 and held it in 4 quarters. The position peaked at $1.53M in Q4 2015. 110 funds tracked by Wall St. Rank hold XENT as of Q1 2016.

Gratus Capital reported no remaining Intersect ENT, Inc position as of Q1 2016 after selling out during the quarter.
Gratus Capital sold 68,091 Intersect ENT, Inc shares in Q1 2016, an estimated $1.53M.
Gratus Capital first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 4 quarters.
Gratus Capital's Intersect ENT, Inc position peaked at $1.53M in Q4 2015.
110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2016.

Based on Gratus Capital's 13F filing for Q1 2016, filed 11 May 2016.